Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 3260
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02421354 | Nivolumab in Treating Patients With Primary Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis, or Post-Polycythemia Vera Myelofibrosis | ||
| NCT03987386 | Conventional or Hypofractionated Radiation Therapy in Treating Patients With Prostate Cancer | ||
| NCT06284460 | Phase I/II Study of a Combination of Decitabine and Cedazuridine (ASTX727) and ASTX029, an ERK Inhibitor, for Patients With RAS Pathway Mutant Myelodysplastic Syndromes and Myelodysplastic/Myeloproliferative Neoplasms | ||
| NCT07415018 | Optimizing Contrast Dose and Scanning Parameters for Detection of Leptomeningeal Disease | ||
| NCT07105020 | iCCARE Project #4: Grounded Theory Study of the Social Determinants of Migrant Health Factors Impacting Prostate Cancer Care and Survivorship Among Sub-Saharan African and Caribbean Immigrant Men Diagnosed With Prostate Cancer | ||
| NCT05529082 | The Attitudes and Beliefs of Hispanic/Latino Individuals Toward Prescription Opioids and Non-Medical Opioid Use | ||
| NCT01143779 | FLT-PET as an Imaging Biomarker With Temsirolimus, Topotecan, and Bortezomib | ||
| NCT02684162 | Guadecitabine and Donor Lymphocyte Infusion in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Relapsing After Allogeneic Stem Cell Transplant | ||
| NCT03426969 | Combination Chemotherapy, Total Body Irradiation, and Donor Blood Stem Cell Transplant in Treating Patients With Primary or Secondary Myelofibrosis | ||
| NCT05502666 | ¡Salud! Por la Vida (SPLV) A Colorectal Screening Promotion Program | ||
| NCT07187869 | Modulation of the Bone Immune Microenvironment Following Cabozantinib Treatment of Bone Metastatic Clear Cell Renal Cell Carcinoma: Proof of Concept Study | ||
| NCT06942286 | Primary HPV Self-Collection in Indonesia | ||
| NCT05226663 | A Radiotracer ([18F]FluorThanatrace) by PET/CT for the Imaging of Breast Cancer | ||
| NCT00610493 | Bevacizumab and Temsirolimus in Patients With Advanced Malignancy | ||
| NCT01737671 | Methotrexate Infusion Into the Fourth Ventricle in Children With Malignant Fourth Ventricular Brain Tumors: A Pilot Study | ||
| NCT00833625 | FDG-PET-CT and Biomarkers in Esophageal Cancer | ||
| NCT03576547 | Venetoclax, Ponatinib, and Dexamethasone in Participants With Philadelphia Chromosome or BCR-ABL Positive Relapsed or Refractory Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia | ||
| NCT06870916 | Supporting Informed Decision Making About Multi-cancer Early Detection Testing | ||
| NCT00543504 | Bevacizumab in Multiple Phase I Combinations | ||
| NCT03425526 | Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease | ||
| NCT00495209 | Pre-Surgical Qigong Therapy for Women With Breast Cancer | ||
| NCT02498899 | Message 2: The Effect of Message Content and Clinical Outcome on Patient's Perception of Physician Compassion | ||
| NCT04771806 | Serial Advanced Magnetic Resonance Imaging Scan for Guidance of Personalized Adaptive Radiotherapy for High Grade Glioma | ||
| NCT02171078 | Post-Treatment Surveillance in Breast Cancer: Bringing CER to the Alliance | ||
| NCT03473730 | Daratumumab in Treating Patients with Muscle Invasive Bladder Cancer or Metastatic Kidney Cancer | ||
| NCT01471067 | Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies | ||
| NCT03136146 | Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia | ||
| NCT02520141 | Ramucirumab in Treating Patients With Advanced or Metastatic, Previously Treated Biliary Cancers That Cannot Be Removed by Surgery | ||
| NCT04989556 | Technology-Enhanced Palliative Care for Advanced Cancer Patients | ||
| NCT04555837 | Alisertib and Pembrolizumab for the Treatment of Patients With Rb-deficient Head and Neck Squamous Cell Cancer | ||
| NCT01970696 | International Ovarian & Testicular Stromal Tumor Registry | ||
| NCT04311723 | Ventilatory Strategy for the Prevention of Atelectasis During Bronchoscopy Under General Anesthesia, VESPA Trial | ||
| NCT05349227 | Comprehensive Outcomes for After Cancer Health | ||
| NCT00411086 | Rituximab and GM-CSF in Treating Patients With Newly Diagnosed Follicular B-Cell Lymphoma | ||
| NCT00592462 | Whole Body Magnetic Resonance Imaging (MRI) for Detection of Cancer Metastases | ||
| NCT04517851 | Elotuzumab for the Treatment of JAK2-Mutated Myelofibrosis | ||
| NCT00756470 | Phase II Neoadjuvant in Inflammatory Breast Cancer | ||
| NCT00895128 | Study of Erlotinib in Combination With Dasatinib | ||
| NCT01894607 | Contrast Enhanced Intraoperative Ultrasound for Detection and Characterization of Renal Mass Undergoing Open Partial Nephrectomy | ||
| NCT00429234 | Gemcitabine and Dasatinib in Advanced Solid Tumors | ||
| NCT01057264 | HAI Abraxane With Gemcitabine and Bevacizumab | ||
| NCT04985565 | Neoadjuvant Dietary Intervention in Intermediate Risk Prostate Cancer | ||
| NCT00707434 | Continuous Glucose Monitoring in Critically Ill | ||
| NCT00067028 | Clofarabine Combinations in Relapsed/Refractory Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS) and Myeloid Blast Phase Chronic Myeloid Leukemia (CML) | ||
| NCT00016367 | Cisplatin and Gemcitabine Plus Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | ||
| NCT00004109 | Doxorubicin Plus External-Beam Radiation Therapy in Treating Patients With Soft Tissue Sarcoma | ||
| NCT01409187 | IPI-Biotherapy for Patients Previously Treated With Cytotoxic Drugs With Metastatic Melanoma | ||
| NCT03225664 | Trametinib and Pembrolizumab in Treating Patients With Recurrent Non-small Cell Lung Cancer That Is Metastatic, Unresectable, or Locally Advanced | ||
| NCT04675710 | Pembrolizumab, Dabrafenib, and Trametinib Before Surgery for the Treatment of BRAF-Mutated Anaplastic Thyroid Cancer | ||
| NCT01994590 | Dovitinib (TKI258) and Abiraterone Acetate in Metastatic Castrate-Resistant Prostate Cancer (mCRPC) |
